In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Bionova Scientific announced Thursday it would bring 200 new jobs to The Woodlands over the next several years, bolstering the community's biotech sector.

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

PCSK9 inhibition may be a suitable alternative for statin-intolerant patients, and recent data demonstrated its efficacy as ...

While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...

Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...

Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

Yale researchers have created a new method for simulating “aging-like” chromosome errors in mouse eggs to better understand ...

The Cambridge research institute launched nearly two years ago with $500 million to support scientific research and development. Approximately 50 staff members will be laid off.

Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species ...